Long-Term Outcomes of Different Surgical Techniques for Sacral Tarlov Cysts: A Prospective Cohort Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorBeijing Jishuitan Hospital

About this trial

Brief Summary

The goal of this observational study is to evaluate the long-term outcomes of different surgical techniques for sacral Tarlov cysts in adult patients aged 18-75 years diagnosed with symptomatic sacral Tarlov cysts. The main questions it aims to answer are:

* Does one surgical technique result in better pain relief (measured by VAS score) and functional recovery (measured by JOA score) compared to others? * How do different surgical techniques impact the long-term recurrence rate and complication rate?

Researchers will compare three surgical techniques:

1. Partial cyst wall resection with nerve root sleeve plasty. 2. Partial cyst wall resection with nerve root sleeve reinforcement and reconstruction. 3. Autologous fat/muscle with fibrin glue microscopic cyst filling.

Participants will:

* Undergo one of the three surgical procedures based on clinical indications. * Complete preoperative and postoperative assessments, including pain and functional scoring, as well as MRI evaluations at baseline and during follow-up. * Participate in a follow-up program for up to 2 years to monitor outcomes and recurrence.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18-75 years.

Diagnosed with symptomatic sacral Tarlov cysts confirmed by MRI.

Persistent sacral or lower back pain (VAS score ≥ 4).

Neurological deficits such as lower extremity numbness or weakness.

Disqualifiers

History of prior sacral Tarlov cyst surgery.

Concurrent spinal conditions requiring separate surgical intervention.

Active infection or systemic inflammatory disease.

Severe comorbidities that increase surgical risk (e.g., advanced cardiac or pulmonary disease).

Trial population

The study population includes adult patients aged 18-75 years diagnosed with symptomatic sacral Tarlov cysts, recruited from the Department of Neurosurgery at Beijing Jishuitan Hospital. Participants must exhibit persistent symptoms such as sacral or lower back pain, neurological deficits (e.g., numbness or weakness in the lower extremities), or bowel/bladder/sexual dysfunction attributable to the cyst, confirmed by MRI. The study focuses on individuals eligible for surgical intervention without significant comorbidities or prior related surgeries. This population represents a clinically relevant cohort for evaluating the efficacy and safety of different surgical techniques for sacral Tarlov cysts.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Partial Cyst Wall Resection with Nerve Root Sleeve Plasty

    Procedure/Surgery

    Surgical technique involving partial removal of the cyst wall to decompress the nerve root, followed by plasty of the nerve root sleeve to restore nerve function and prevent recurrence.

  • Partial Cyst Wall Resection with Nerve Root Sleeve Reinforcement and Reconstruction:

    Procedure/Surgery

    Advanced surgical technique combining partial cyst wall removal with additional reinforcement and reconstruction of the nerve root sleeve to provide enhanced support and reduce the risk of cyst recurrence.

  • Autologous Fat/Muscle with Fibrin Glue Microscopic Cyst Filling

    Procedure/Surgery

    Minimally invasive surgical technique where autologous fat or muscle tissue is used to fill the cyst cavity, and fibrin glue is applied to seal the defect, aiming to obliterate the cyst and prevent cerebrospinal fluid leakage.

Treatment groups

150 Participants
are divided into 3 treatment groups
Group A: Partial Cyst Wall Resection with Nerve Root Sleeve Plasty1 intervention
Group B: Partial Cyst Wall Resection with Nerve Root Sleeve Reinforcement and Reconstruction1 intervention
Group C: Autologous Fat/Muscle with Fibrin Glue Microscopic Cyst Filling1 intervention

Trial outcomes

Primary outcomes

1

Pain Reduction Assessed by Visual Analog Scale (VAS)

Time frame
Baseline, 1 month, 3 months, 6 months, 12 months and 24 months postoperatively
2

Neurological Function Improvement Assessed by Japanese Orthopedic Association (JOA) Score

Time frame
Baseline, 1 month, 3 months, 6 months, 12 months and 24 months postoperatively

Secondary outcomes

1

Recurrence Rate of Sacral Tarlov Cysts

Time frame
12 months postoperatively and annually up to 2 years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: